Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Cardiovascular Device

PUBLISHER: Data Bridge Market Research | PRODUCT CODE: 1239972

Cover Image

PUBLISHER: Data Bridge Market Research | PRODUCT CODE: 1239972

North America Left Ventricular Assist Device (LVAD) Market - Industry Trends and Forecast to 2029

PUBLISHED:
PAGES: 166 Pages
DELIVERY TIME: Inquiry
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License) - Printable/Downloadable
USD 3500
PDF (Enterprise License) - Printable/Downloadable
USD 4200

Add to Cart

Description

Table of Contents

List of Tables

North America left ventricular device (LVAD) market is projected to register a substantial CAGR of 9.6% in the forecast period of 2022 to 2029. The new market report contains data for the historic year 2020, the base year of calculation is 2021, and the forecast period is 2022 to 2029.

Market Segmentation:

North America Left Ventricular Assist Device (LVAD) Market, By Product Type (Heart Pump, Controller, Batteries, and Wires), Therapy (Bridge-To-Transplant (BTT) Therapy, Destination Therapy, Bridge-To-Candidacy (BTC) Therapy, and Bridge-To-Recovery (BTR) Therapy), Age Group (Adult and Pediatric), Generation (Second Generation Devices, Third Generation Devices, and First Generation Devices), Durability (Long-Term, Intermediate-Term, and Short-Term), design (Axial and centrifugal), Pulse Type (Nonpulsatile and Pulsatile), End User (Hospitals Cardiac Cath Laboratories, Specialty Clinics, and Others), Distribution Channel (Direct Tender, Retail Sales, and Others), Country (North America), Region (U.S., Canada, and Mexico), - Industry Trends & Forecast to 2029.

Some of the major factors contributing to the growth of the North America left ventricular device (LVAD) market are:

Increasing geriatric population along with rising prevalence of cardiac diseases

Strong emphasis on R&D exercises aimed at the development of progressively enticing devices

Market Players:

Some of the key market players for North America left ventricular device (LVAD) market are listed below:

ABIOMED

Abbott

Evaheart, Inc.

Saft

Berlin Heart

Jarvik Heart, Inc.

Show more

TABLE OF CONTENTS

1 INTRODUCTION 17

  • 1.1 OBJECTIVES OF THE STUDY 17
  • 1.2 MARKET DEFINITION 17
  • 1.3 OVERVIEW OF NORTH AMERICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET 17
  • 1.4 LIMITATIONS 20
  • 1.5 MARKETS COVERED 20

2 MARKET SEGMENTATION 23

  • 2.1 MARKETS COVERED 23
  • 2.2 GEOGRAPHICAL SCOPE 24
  • 2.3 YEARS CONSIDERED FOR THE STUDY 24
  • 2.4 CURRENCY AND PRICING 24
  • 2.5 DBMR TRIPOD DATA VALIDATION MODEL 25
  • 2.6 MULTIVARIATE MODELLING 28
  • 2.7 PRODUCT TYPE LIFELINE CURVE 28
  • 2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 29
  • 2.9 DBMR MARKET POSITION GRID 30
  • 2.10 MARKET END USER COVERAGE GRID 31
  • 2.11 VENDOR SHARE ANALYSIS 32
  • 2.12 SECONDARY SOURCES 33
  • 2.13 ASSUMPTIONS 33

3 EXECUTIVE SUMMARY 34

4 PREMIUM INSIGHTS 37

  • 4.1 PESTEL 38
  • 4.2 PORTER'S 39
  • 4.3 INDUSTRIAL INSIGHTS: 40

5 NORTH AMERICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: REGULATIONS 41

  • 5.1 REGULATION IN U.S. 41
    • 5.1.1 GUIDELINES- 41
  • 5.2 REGULATION IN CANADA 42
    • 5.2.1 GUIDELINES FOR THE MANUFACTURERS: 42
  • 5.3 REGULATION IN MEXICO 43
    • 5.3.1 GUIDELINES FOR THE MANUFACTURERS: 43

6 MARKET OVERVIEW 44

  • 6.1 DRIVERS 46
    • 6.1.1 INCREASING GERIATRIC POPULATION ALONG WITH RISING PREVALENCE OF CARDIAC DISEASES 46
    • 6.1.2 PRESENCE OF FAVOURABLE REIMBURSEMENT POLICIES 46
    • 6.1.3 CHANGING LIFESTYLE TRIGGERS THE DEVELOPMENT OF CARDIOVASCULAR DISEASES 47
  • 6.2 RESTRAINTS 47
    • 6.2.1 HIGH COST OF LVAD IMPLANTATION AND TREATMENT 47
    • 6.2.2 COMPLICATIONS AND RISKS ASSOCIATED WITH LVAD 48
  • 6.3 OPPORTUNITIES 49
    • 6.3.1 INCREASE IN HEALTHCARE EXPENDITURE 49
    • 6.3.2 INCREASE IN MINIMALLY INVASIVE PROCEDURE 49
    • 6.3.3 INCREASING SHORTAGE OF ORGAN DONORS 49
    • 6.3.4 TECHNOLOGICAL ADVANCEMENTS IN LEFT VENTRICULAR ASSIST DEVICES 50
  • 6.4 CHALLENGES 50
    • 6.4.1 ONGOING COVID-19 50
    • 6.4.2 INCREASE IN PRODUCT RECALL 50

7 NORTH AMERICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE 52

  • 7.1 OVERVIEW 53
  • 7.2 HEART PUMP 56
  • 7.3 CONTROLLER 56
  • 7.4 BATTERIES 57
    • 7.4.1 RECHARGEABLE 58
    • 7.4.2 NON-RECHARGEABLE 58
  • 7.5 WIRES 58

8 NORTH AMERICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY 59

  • 8.1 OVERVIEW 60
  • 8.2 BRIDGE-TO-TRANSPLANT (BTT) THERAPY 63
    • 8.2.1 HEART PUMP 63
    • 8.2.2 CONTROLLER 64
    • 8.2.3 BATTERIES 64
    • 8.2.4 WIRES 64
  • 8.3 DESTINATION THERAPY 64
    • 8.3.1 HEART PUMP 65
    • 8.3.2 CONTROLLER 65
    • 8.3.3 BATTERIES 65
    • 8.3.4 WIRES 65
  • 8.4 BRIDGE-TO-CANDIDACY (BTC) THERAPY 65
    • 8.4.1 HEART PUMP 66
    • 8.4.2 CONTROLLER 66
    • 8.4.3 BATTERIES 66
    • 8.4.4 WIRES 66
  • 8.5 BRIDGE-TO-RECOVERY (BTR) THERAPY 66
    • 8.5.1 HEART PUMP 67
    • 8.5.2 CONTROLLER 67
    • 8.5.3 BATTERIES 67
    • 8.5.4 WIRES 68

9 NORTH AMERICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP 69

  • 9.1 OVERVIEW 70
  • 9.2 ADULT 73
    • 9.2.1 19-39 YEARS 73
    • 9.2.2 40-59 YEARS 73
    • 9.2.3 60-79 YEARS 73
    • 9.2.4 ABOVE 80 YEARS 74
  • 9.3 PEDIATRIC 74

10 NORTH AMERICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY GENERATION 75

  • 10.1 OVERVIEW 76
  • 10.2 SECOND GENERATION DEVICES 79
  • 10.3 THIRD GENERATION DEVICES 79
  • 10.4 FIRST GENERATION DEVICES 80

11 NORTH AMERICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DESIGN 81

  • 11.1 OVERVIEW 82
  • 11.2 AXIAL 85
  • 11.3 CENTRIFUGAL 85

12 NORTH AMERICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION 86

  • 12.1 OVERVIEW 87
  • 12.2 CONGESTIVE HEART FAILURE 90
    • 12.2.1 HEART PUMP 90
    • 12.2.2 CONTROLLER 90
    • 12.2.3 BATTERIES 90
    • 12.2.4 WIRES 90
  • 12.3 CONGENITAL HEART DISEASE 91
    • 12.3.1 HEART PUMP 91
    • 12.3.2 CONTROLLER 91
    • 12.3.3 BATTERIES 92
    • 12.3.4 WIRES 92
  • 12.4 MYOCARDITIS 92
    • 12.4.1 HEART PUMP 92
    • 12.4.2 CONTROLLER 93
    • 12.4.3 BATTERIES 93
    • 12.4.4 WIRES 93
  • 12.5 CARDIAC ARREST 93
    • 12.5.1 HEART PUMP 94
    • 12.5.2 CONTROLLER 94
    • 12.5.3 BATTERIES 94
    • 12.5.4 WIRES 94
  • 12.6 FAMILIAL ARRHYTHMIAS AND ARRHYTHMIC CARDIOMYOPATHIES 94
    • 12.6.1 HEART PUMP 95
    • 12.6.2 CONTROLLER 95
    • 12.6.3 BATTERIES 95
    • 12.6.4 WIRES 95
  • 12.7 ADVANCED HEART FAILURE 96
    • 12.7.1 HEART PUMP 96
    • 12.7.2 CONTROLLER 96
    • 12.7.3 BATTERIES 96
    • 12.7.4 WIRES 97
  • 12.8 OTHERS 97

13 NORTH AMERICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) DISEASE MARKET, BY DURABILITY 98

  • 13.1 OVERVIEW 99
  • 13.2 LONG-TERM 102
  • 13.3 INTERMEDIATE-TERM 102
  • 13.4 SHORT-TERM 102

14 NORTH AMERICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) DISEASE MARKET, BY PULSE TYPE 104

  • 14.1 OVERVIEW 105
  • 14.2 NONPULSATILE 108
  • 14.3 PULSATILE 108

15 NORTH AMERICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) DISEASE MARKET, BY END USER 109

  • 15.1 OVERVIEW 110
  • 15.2 HOSPITAL 113
  • 15.3 CARDIAC CATH LABORATORIES 113
  • 15.4 SPECIALTY CLINICS 114
  • 15.5 OTHERS 114

16 NORTH AMERICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) DISEASE MARKET, BY DISTRIBUTION CHANNEL 115

  • 16.1 OVERVIEW 116
  • 16.2 DIRECT TENDER 119
  • 16.3 RETAIL SALES 119
  • 16.4 OTHERS 120

17 NORTH AMERICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY NORTH AMERICA 121

  • 17.1 NORTH AMERICA 121
    • 17.1.1 U.S. 127
    • 17.1.2 CANADA 133
    • 17.1.3 MEXICO 139

18 NORTH AMERICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: COMPANY LANDSCAPE 145

  • 18.1 COMPANY SHARE ANALYSIS: NORTH AMERICA 145

19 SWOT ANALYSIS 146

20 COMPANY PROFILE 147

  • 20.1 ABIOMED 147
    • 20.1.1 COMPANY SNAPSHOT 147
    • 20.1.2 REVENUE ANALYSIS 147
    • 20.1.3 COMPANY SHARE ANALYSIS 148
    • 20.1.4 PRODUCT PORTFOLIO 148
    • 20.1.5 RECENT DEVELOPMENTS 149
      • 20.1.5.1 FDA APPROVAL 149
      • 20.1.5.2 FDA APPROVAL 149
  • 20.2 ABBOTT 150
    • 20.2.1 COMPANY SNAPSHOT 150
    • 20.2.2 REVENUE ANALYSIS 150
    • 20.2.3 COMPANY SHARE ANALYSIS 151
    • 20.2.4 PRODUCT PORTFOLIO 151
    • 20.2.5 RECENT DEVELOPMENTS 151
      • 20.2.5.1 SUPPLY INCREMENT 151
      • 20.2.5.2 BREAK THROUGH DEVICE DESIGNATION 152
  • 20.3 BERLIN HEART 153
    • 20.3.1 COMPANY SNAPSHOT 153
    • 20.3.2 COMPANY SHARE ANALYSIS 153
    • 20.3.3 PRODUCT PORTFOLIO 154
    • 20.3.4 RECENT DEVELOPMENT 154
      • 20.3.4.1 PRODUCT APPROVAL 154
  • 20.4 SAFT (A SUBSIDIARY OF TOTALENERGIES) 155
    • 20.4.1 COMPANY SNAPSHOT 155
    • 20.4.2 REVENUE ANALYSIS 155
    • 20.4.3 COMPANY SHARE ANALYSIS 156
    • 20.4.4 PRODUCT PORTFOLIO 156
    • 20.4.5 RECENT DEVELOPMENT 156
      • 20.4.5.1 PARTNERSHIP 156
  • 20.5 JARVIK HEART, INC. 157
    • 20.5.1 COMPANY SNAPSHOT 157
    • 20.5.2 COMPANY SHARE ANALYSIS 157
    • 20.5.3 PRODUCT PORTFOLIO 157
    • 20.5.4 RECENT DEVELOPMENT 158
      • 20.5.4.1 FDA APPROVAL 158
  • 20.6 CORWAVE SA 159
    • 20.6.1 COMPANY SNAPSHOT 159
    • 20.6.2 PRODUCT PORTFOLIO 159
    • 20.6.3 RECENT DEVELOPMENT 159
      • 20.6.3.1 EXPANSION 159
  • 20.7 EVAHEART, INC 160
    • 20.7.1 COMPANY SNAPSHOT 160
    • 20.7.2 PRODUCT PORTFOLIO 160
    • 20.7.3 RECENT DEVELOPMENT 160
      • 20.7.3.1 PRODUCT TRIAL 160

21 QUESTIONNAIRE 161

22 RELATED REPORTS 166

Show more

LIST OF TABLES

  • TABLE 1 NORTH AMERICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION) 55
  • TABLE 2 NORTH AMERICA BATTERIES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION) 56
  • TABLE 3 NORTH AMERICA BATTERIES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION) 57
  • TABLE 4 NORTH AMERICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION) 62
  • TABLE 5 NORTH AMERICA BRIDGE-TO-TRANSPLANT (BTT) THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION) 63
  • TABLE 6 NORTH AMERICA DESTINATION THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION) 65
  • TABLE 7 NORTH AMERICA BRIDGE-TO-CANDIDACY (BTC) THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION) 66
  • TABLE 8 NORTH AMERICA BRIDGE-TO-RECOVERY (BTR) THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION) 67
  • TABLE 9 NORTH AMERICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION) 72
  • TABLE 10 NORTH AMERICA ADULT IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION) 73
  • TABLE 11 NORTH AMERICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY GENERATION, 2020-2029 (USD MILLION) 78
  • TABLE 12 NORTH AMERICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DESIGN, 2020-2029 (USD MILLION) 84
  • TABLE 13 NORTH AMERICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION) 89
  • TABLE 14 NORTH AMERICA CONGESTIVE HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION) 90
  • TABLE 15 NORTH AMERICA CONGENITAL HEART DISEASE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION) 91
  • TABLE 16 NORTH AMERICA MYOCARDITIS IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION) 92
  • TABLE 17 NORTH AMERICA CARDIAC ARREST IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION) 94
  • TABLE 18 NORTH AMERICA FAMILIAL ARRHYTHMIAS AND ARRHYTHMIC CARDIOMYOPATHIES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION) 95
  • TABLE 19 NORTH AMERICA ADVANCED HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION) 96
  • TABLE 20 NORTH AMERICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DURABILITY, 2020-2029 (USD MILLION) 101
  • TABLE 21 NORTH AMERICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PULSE TYPE, 2020-2029 (USD MILLION) 107
  • TABLE 22 NORTH AMERICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY END USER, 2020-2029 (USD MILLION) 112
  • TABLE 23 NORTH AMERICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 118
  • TABLE 24 U.S. LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION) 127
  • TABLE 25 U.S. LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS) 127
  • TABLE 26 U.S. BATTERIES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION) 127
  • TABLE 27 U.S. LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION) 127
  • TABLE 28 U.S. BRIDGE-TO-TRANSPLANT (BTT) THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION) 128
  • TABLE 29 U.S. DESTINATION THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION) 128
  • TABLE 30 U.S. BRIDGE-TO-CANDIDACY (BTC) THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION) 128
  • TABLE 31 U.S. BRIDGE-TO-RECOVERY (BTR) THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION) 128
  • TABLE 32 U.S. LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION) 129
  • TABLE 33 U.S. ADULT IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION) 129
  • TABLE 34 U.S. LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION) 129
  • TABLE 35 U.S. CONGESTIVE HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION) 129
  • TABLE 36 U.S. CONGENITAL HEART DISEASE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION) 130
  • TABLE 37 U.S. MYOCARDITIS IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION) 130
  • TABLE 38 U.S. CARDIAC ARREST IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION) 130
  • TABLE 39 U.S. FAMILIAL ARRHYTHMIAS AND ARRHYTHMIC CARDIOMYOPATHIES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION) 130
  • TABLE 40 U.S. ADVANCED HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION) 131
  • TABLE 41 U.S. LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY GENERATION, 2020-2029 (USD MILLION) 131
  • TABLE 42 U.S. LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DURABILITY, 2020-2029 (USD MILLION) 131
  • TABLE 43 U.S. LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DESIGN, 2020-2029 (USD MILLION) 131
  • TABLE 44 U.S. LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PULSE TYPE, 2020-2029 (USD MILLION) 132
  • TABLE 45 U.S. LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY END USER, 2020-2029 (USD MILLION) 132
  • TABLE 46 U.S. LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 132
  • TABLE 47 CANADA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION) 133
  • TABLE 48 CANADA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS) 133
  • TABLE 49 CANADA BATTERIES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION) 133
  • TABLE 50 CANADA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION) 133
  • TABLE 51 CANADA BRIDGE-TO-TRANSPLANT (BTT) THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION) 134
  • TABLE 52 CANADA DESTINATION THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION) 134
  • TABLE 53 CANADA BRIDGE-TO-CANDIDACY (BTC) THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION) 134
  • TABLE 54 CANADA BRIDGE-TO-RECOVERY (BTR) THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION) 134
  • TABLE 55 CANADA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION) 135
  • TABLE 56 CANADA ADULT IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION) 135
  • TABLE 57 CANADA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION) 135
  • TABLE 58 CANADA CONGESTIVE HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION) 135
  • TABLE 59 CANADA CONGENITAL HEART DISEASE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION) 136
  • TABLE 60 CANADA MYOCARDITIS IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION) 136
  • TABLE 61 CANADA CARDIAC ARREST IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION) 136
  • TABLE 62 CANADA FAMILIAL ARRHYTHMIAS AND ARRHYTHMIC CARDIOMYOPATHIES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION) 136
  • TABLE 63 CANADA ADVANCED HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION) 137
  • TABLE 64 CANADA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY GENERATION, 2020-2029 (USD MILLION) 137
  • TABLE 65 CANADA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DURABILITY, 2020-2029 (USD MILLION) 137
  • TABLE 66 CANADA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DESIGN, 2020-2029 (USD MILLION) 137
  • TABLE 67 CANADA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PULSE TYPE, 2020-2029 (USD MILLION) 138
  • TABLE 68 CANADA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY END USER, 2020-2029 (USD MILLION) 138
  • TABLE 69 CANADA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 138
  • TABLE 70 MEXICO LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION) 139
  • TABLE 71 MEXICO LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS) 139
  • TABLE 72 MEXICO BATTERIES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION) 139
  • TABLE 73 MEXICO LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION) 139
  • TABLE 74 MEXICO BRIDGE-TO-TRANSPLANT (BTT) THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION) 140
  • TABLE 75 MEXICO DESTINATION THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION) 140
  • TABLE 76 MEXICO BRIDGE-TO-CANDIDACY (BTC) THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION) 140
  • TABLE 77 MEXICO BRIDGE-TO-RECOVERY (BTR) THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION) 140
  • TABLE 78 MEXICO LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION) 141
  • TABLE 79 MEXICO ADULT IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION) 141
  • TABLE 80 MEXICO LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION) 141
  • TABLE 81 MEXICO CONGESTIVE HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION) 141
  • TABLE 82 MEXICO CONGENITAL HEART DISEASE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION) 142
  • TABLE 83 MEXICO MYOCARDITIS IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION) 142
  • TABLE 84 MEXICO CARDIAC ARREST IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION) 142
  • TABLE 85 MEXICO FAMILIAL ARRHYTHMIAS AND ARRHYTHMIC CARDIOMYOPATHIES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION) 142
  • TABLE 86 MEXICO ADVANCED HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION) 143
  • TABLE 87 MEXICO LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY GENERATION, 2020-2029 (USD MILLION) 143
  • TABLE 88 MEXICO LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DURABILITY, 2020-2029 (USD MILLION) 143
  • TABLE 89 MEXICO LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DESIGN, 2020-2029 (USD MILLION) 143
  • TABLE 90 MEXICO LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PULSE TYPE, 2020-2029 (USD MILLION) 144
  • TABLE 91 MEXICO LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY END USER, 2020-2029 (USD MILLION) 144
  • TABLE 92 MEXICO LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 144

LIST OF FIGURES

  • FIGURE 1 NORTH AMERICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: SEGMENTATION 23
  • FIGURE 2 NORTH AMERICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: DATA TRIANGULATION 25
  • FIGURE 3 NORTH AMERICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: DROC ANALYSIS 26
  • FIGURE 4 NORTH AMERICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: NORTH AMERICA VS REGIONAL ANALYSIS 27
  • FIGURE 5 NORTH AMERICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: COMPANY RESEARCH ANALYSIS 27
  • FIGURE 6 NORTH AMERICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: INTERVIEW DEMOGRAPHICS 29
  • FIGURE 7 NORTH AMERICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: DBMR MARKET POSITION GRID 30
  • FIGURE 8 NORTH AMERICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: END USER COVERAGE GRID 31
  • FIGURE 9 NORTH AMERICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET:VENDOR SHARE ANALYSIS 32
  • FIGURE 10 NORTH AMERICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: SEGMENTATION 36
  • FIGURE 11 INCREASING PREVALENCE OF CARDIOVASCULAR DISEASE AND RISING HEALTHCARE EXPENDITURE ARE EXPECTED TO DRIVE THE NORTH AMERICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET IN THE FORECAST PERIOD OF 2022 TO 2029 37
  • FIGURE 12 HEART PUMP SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET IN 2022 & 2029 37
  • FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF NORTH AMERICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET 45
  • FIGURE 14 NORTH AMERICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: BY PRODUCT TYPE, 2021 53
  • FIGURE 15 NORTH AMERICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: BY PRODUCT TYPE, 2020-2029 (USD MILLION) 54
  • FIGURE 16 NORTH AMERICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: BY PRODUCT TYPE, CAGR (2022-2029) 54
  • FIGURE 17 NORTH AMERICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: BY PRODUCT TYPE, LIFELINE CURVE 55
  • FIGURE 18 NORTH AMERICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: BY THERAPY, 2021 60
  • FIGURE 19 NORTH AMERICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: BY THERAPY, 2020-2029 (USD MILLION) 61
  • FIGURE 20 NORTH AMERICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: BY THERAPY, CAGR (2022-2029) 61
  • FIGURE 21 NORTH AMERICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: BY THERAPY, LIFELINE CURVE 62
  • FIGURE 22 NORTH AMERICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: BY AGE GROUP, 2021 70
  • FIGURE 23 NORTH AMERICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: BY AGE GROUP, 2020-2029 (USD MILLION) 71
  • FIGURE 24 NORTH AMERICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: BY AGE GROUP, CAGR (2022-2029) 71
  • FIGURE 25 NORTH AMERICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: BY AGE GROUP, LIFELINE CURVE 72
  • FIGURE 26 NORTH AMERICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: BY GENERATION, 2021 76
  • FIGURE 27 NORTH AMERICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: BY GENERATION, 2020-2029 (USD MILLION) 77
  • FIGURE 28 NORTH AMERICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: BY GENERATION, CAGR (2022-2029) 77
  • FIGURE 29 NORTH AMERICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: BY GENERATION, LIFELINE CURVE 78
  • FIGURE 30 NORTH AMERICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: BY DESIGN, 2021 82
  • FIGURE 31 NORTH AMERICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: BY DESIGN, 2020-2029 (USD MILLION) 83
  • FIGURE 32 NORTH AMERICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: BY DESIGN, CAGR (2022-2029) 83
  • FIGURE 33 NORTH AMERICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: BY DESIGN, LIFELINE CURVE 84
  • FIGURE 34 NORTH AMERICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) DISEASE MARKET: BY INDICATION, 2021 87
  • FIGURE 35 NORTH AMERICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) DISEASE MARKET: BY INDICATION, 2020-2029 (USD MILLION) 88
  • FIGURE 36 NORTH AMERICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) DISEASE MARKET: BY INDICATION, CAGR (2022-2029) 88
  • FIGURE 37 NORTH AMERICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) DISEASE MARKET: BY INDICATION, LIFELINE CURVE 89
  • FIGURE 38 NORTH AMERICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) DISEASE MARKET: BY DURABILITY, 2021 99
  • FIGURE 39 NORTH AMERICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) DISEASE MARKET: BY DURABILITY, 2020-2029 (USD MILLION) 100
  • FIGURE 40 NORTH AMERICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) DISEASE MARKET: BY DURABILITY, CAGR (2022-2029) 100
  • FIGURE 41 NORTH AMERICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) DISEASE MARKET: BY DURABILITY, LIFELINE CURVE 101
  • FIGURE 42 NORTH AMERICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) DISEASE MARKET: BY PULSE TYPE, 2021 105
  • FIGURE 43 NORTH AMERICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) DISEASE MARKET: BY PULSE TYPE, 2020-2029 (USD MILLION) 106
  • FIGURE 44 NORTH AMERICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) DISEASE MARKET: BY PULSE TYPE, CAGR (2022-2029) 106
  • FIGURE 45 NORTH AMERICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) DISEASE MARKET: BY PULSE TYPE, LIFELINE CURVE 107
  • FIGURE 46 NORTH AMERICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) DISEASE MARKET: BY END USER, 2021 110
  • FIGURE 47 NORTH AMERICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) DISEASE MARKET: BY END USER, 2020-2029 (USD MILLION) 111
  • FIGURE 48 NORTH AMERICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) DISEASE MARKET: BY END USER, CAGR (2022-2029) 111
  • FIGURE 49 NORTH AMERICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) DISEASE MARKET: BY END USER, LIFELINE CURVE 112
  • FIGURE 50 NORTH AMERICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) DISEASE MARKET: BY DISTRIBUTION CHANNEL, 2021 116
  • FIGURE 51 NORTH AMERICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) DISEASE MARKET: BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 117
  • FIGURE 52 NORTH AMERICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) DISEASE MARKET: BY DISTRIBUTION CHANNEL, CAGR (2022-2029) 117
  • FIGURE 53 NORTH AMERICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) DISEASE MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE 118
  • FIGURE 54 NORTH AMERICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: SNAPSHOT (2021) 122
  • FIGURE 55 NORTH AMERICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: BY COUNTRY (2021) 124
  • FIGURE 56 NORTH AMERICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: BY COUNTRY (2022 & 2029) 124
  • FIGURE 57 NORTH AMERICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: BY COUNTRY (2021 & 2029) 125
  • FIGURE 58 NORTH AMERICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: BY PRODUCT TYPE (2022-2029) 126
  • FIGURE 59 NORTH AMERICA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: COMPANY SHARE 2021 (%) 145
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!